Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cisplatin Induces Overactivation of the Dormant Primordial Follicle through PTEN/AKT/FOXO3a Pathway which Leads to Loss of Ovarian Reserve in Mice
Eun Mi Chang, Eun‐Jin Lim, Sook-Young Yoon, et al.
PLoS ONE (2015) Vol. 10, Iss. 12, pp. e0144245-e0144245
Open Access | Times Cited: 135

Showing 1-25 of 135 citing articles:

Ovarian damage from chemotherapy and current approaches to its protection
Norah Spears, Federica Lopes, Agnes Stefansdottir, et al.
Human Reproduction Update (2019) Vol. 25, Iss. 6, pp. 673-693
Open Access | Times Cited: 486
mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy
Kara N. Goldman, Devon M. Chenette, Rezina Arju, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 12, pp. 3186-3191
Open Access | Times Cited: 147
Melatonin prevents cisplatin‐induced primordial follicle loss via suppression of PTEN/AKT/FOXO3a pathway activation in the mouse ovary
Hoon Jang, Ok‐Hee Lee, Young Eun Lee, et al.
Journal of Pineal Research (2016) Vol. 60, Iss. 3, pp. 336-347
Closed Access | Times Cited: 146
Crosstalk between PTEN/PI3K/Akt Signalling and DNA Damage in the Oocyte: Implications for Primordial Follicle Activation, Oocyte Quality and Ageing
Mila Maidarti, Richard A. Anderson, Evelyn E. Telfer
Cells (2020) Vol. 9, Iss. 1, pp. 200-200
Open Access | Times Cited: 134
AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide‐treated mice
Charlotte Sonigo, Isabelle Beau, Michaël Grynberg, et al.
The FASEB Journal (2018) Vol. 33, Iss. 1, pp. 1278-1287
Closed Access | Times Cited: 115
Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes
Quynh‐Nhu Nguyen, Nadeen Zerafa, Seng H. Liew, et al.
Molecular Human Reproduction (2019) Vol. 25, Iss. 8, pp. 433-444
Closed Access | Times Cited: 108
Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility
Quynh-Nhu Nguyen, Nadeen Zerafa, Seng H. Liew, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 6
Open Access | Times Cited: 106
Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity†
Ricássio de Sousa Barberino, Vanúzia Gonçalves Menezes, Anita Eugênia Alencar Santos Ribeiro, et al.
Biology of Reproduction (2017) Vol. 96, Iss. 6, pp. 1244-1255
Closed Access | Times Cited: 104
Molecular Mechanism and Prevention Strategy of Chemotherapy- and Radiotherapy-Induced Ovarian Damage
Seongmin Kim, Sung Woo Kim, Soo-Jin Han, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7484-7484
Open Access | Times Cited: 67
FOXO3a in cancer drug resistance
Ying Liu, Yu Wang, Xiaoge Li, et al.
Cancer Letters (2022) Vol. 540, pp. 215724-215724
Closed Access | Times Cited: 54
Dual suppression of follicle activation pathways completely prevents the cyclophosphamide-induced loss of ovarian reserve
Oren Kashi, Hadassa Roness, Itai Spector, et al.
Human Reproduction (2023) Vol. 38, Iss. 6, pp. 1086-1098
Closed Access | Times Cited: 24
Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage
Yican Guo, Liru Xue, Weicheng Tang, et al.
Human Reproduction Update (2024) Vol. 30, Iss. 5, pp. 614-647
Open Access | Times Cited: 14
Synergistic effect of melatonin and ghrelin in preventing cisplatin‐induced ovarian damage via regulation of FOXO3a phosphorylation and binding to the p27Kip1 promoter in primordial follicles
Hoon Jang, Younghwa Na, Kwonho Hong, et al.
Journal of Pineal Research (2017) Vol. 63, Iss. 3
Closed Access | Times Cited: 76
The Impact of Chemotherapy on the Ovaries: Molecular Aspects and the Prevention of Ovarian Damage
Charlotte Sonigo, Isabelle Beau, Nadine Binart, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5342-5342
Open Access | Times Cited: 74
Primordial follicle activation as new treatment for primary ovarian insufficiency
Hye Nam Lee, Eun Mi Chang
Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine (2019) Vol. 46, Iss. 2, pp. 43-49
Open Access | Times Cited: 71
Ovarian Follicle Depletion Induced by Chemotherapy and the Investigational Stages of Potential Fertility-Protective Treatments—A Review
Xia Hao, Amandine Anastácio, Kui Liu, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 19, pp. 4720-4720
Open Access | Times Cited: 70
Recovery of ovarian function by human embryonic stem cell-derived mesenchymal stem cells in cisplatin-induced premature ovarian failure in mice
Sook Young Yoon, Jung Ah Yoon, Mira Park, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 69
A Network Pharmacology Approach to Explore the Pharmacological Mechanism of Xiaoyao Powder on Anovulatory Infertility
Huiping Liu, Liuting Zeng, Kailin Yang, et al.
Evidence-based Complementary and Alternative Medicine (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 65
Doxorubicin obliterates mouse ovarian reserve through both primordial follicle atresia and overactivation
Yingzheng Wang, Mingjun Liu, Sarah Johnson, et al.
Toxicology and Applied Pharmacology (2019) Vol. 381, pp. 114714-114714
Open Access | Times Cited: 61
Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell
Akimasa Takahashi, Abdelrahman Yousif, Linda Hong, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 5, pp. 637-650
Closed Access | Times Cited: 55
Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging
Katarzyna Szymanska, Xiujuan Tan, Kutluk Oktay
Molecular Human Reproduction (2020) Vol. 26, Iss. 8, pp. 553-566
Open Access | Times Cited: 54
Rutin prevents cisplatin-induced ovarian damage via antioxidant activity and regulation of PTEN and FOXO3a phosphorylation in mouse model
T.L.B.G. Lins, B.B. Gouveia, Ricássio de Sousa Barberino, et al.
Reproductive Toxicology (2020) Vol. 98, pp. 209-217
Closed Access | Times Cited: 51
Implications of Nonphysiological Ovarian Primordial Follicle Activation for Fertility Preservation
Johanne Grosbois, Melody Devos, Isabelle Demeestere
Endocrine Reviews (2020) Vol. 41, Iss. 6, pp. 847-872
Open Access | Times Cited: 50
Current and Future Perspectives for Improving Ovarian Tissue Cryopreservation and Transplantation Outcomes for Cancer Patients
Sanghoon Lee, Sinan Özkavukçu, Seung‐Yup Ku
Reproductive Sciences (2021) Vol. 28, Iss. 6, pp. 1746-1758
Open Access | Times Cited: 45
Melatonin Mitigates Cisplatin-Induced Ovarian Dysfunction via Altering Steroidogenesis, Inflammation, Apoptosis, Oxidative Stress, and PTEN/PI3K/Akt/mTOR/AMPK Signaling Pathway in Female Rats
Amal Al-Shahat, Mohey Hulail, Nada M. M. Soliman, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2769-2769
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top